|

ALETA-001 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Cancer Research UK1

Indications

  • Lymphoma, Mantle-Cell1
  • Lymphoma, Follicular1
  • Lymphoma, Large B-Cell, Diffuse1
  • Lymphoma, B-Cell1
  • Large B-cell Lymphoma1

Other1 trial

A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.